The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells

Seo Yun Kim, Cheol Hyeon Kim(National Cancer Center)
Anticancer Research
June 1, 2021
Cited by 10


Related Papers